Neuromonics provides the only FDA approved treatment for tinnitus, a neurological condition evidenced by a chronic ringing in the ears. The uniquely patented device and the associated treatment, which has been under development for over 10 years, has been through extensive refinement through ongoing research and multiple clinical trials. The product, originally launched in Australia, has shown widespread acceptance and validation with over 1000 patients having completed treatment.